Search

Reset

Status

Medical Condition

Displaying 1 - 2 of 2

Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)

Condition: Liver Disease
Investigator: Gene Im, MD, FAASLD
Status: Currently Recruiting
Researchers at Columbia University Irving Medical Center are studying whether an investigational medication called larsucosterol, when added to standard medical care, may improve outcomes for people with severe alcohol-associated hepatitis. Alcohol-associated hepatitis is a serious inflammation…
Read More

Study to Test if BI 3802876 is Tolerated in People W/ Compensated Liver Cirrhosis Due to Metabolic Dysfunction-Associated Steatohepatitis

Condition: Liver Disease / MASH (formerly NASH)
Investigator: Julia Wattacheril, MD, MPH
Status: Currently Recruiting
The purpose of this research study is to determine how well BI3802876 is tolerated in people living with cirrhosis due to a liver condition called metabolic dysfunction-associated steatohepatitis (MASH, formerly known as NASH). The study medication, BI3802876, is investigational, meaning it has not yet been approved by the…
Read More